Cigna Group (CI) Stock Forecast & Price Target

$275.26 +4.76 (+1.76%)

Closing price 03:59 PM Eastern

Extended Trading

$274.88 -0.39 (-0.14%)

As of 06:37 PM Eastern

Compare

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 22 Analyst Ratings

Sell
0

Hold
7

Buy
15

Based on 22 Wall Street analysts who have issued ratings for Cigna Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 7 have given a hold rating, and 15 have given a buy rating for CI.

Consensus Price Target

$339.45
23.32% Upside

According to the 22 analysts' twelve-month price targets for Cigna Group, the average price target is $339.45. The highest price target for CI is $400.00, while the lowest price target for CI is $297.00. The average price target represents a forecasted upside of 23.32% from the current price of $275.26.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cigna Group and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CI Analyst Ratings Over Time

Type	Current Forecast 8/6/25 to 8/6/26	1 Month Ago 7/7/25 to 7/7/26	3 Months Ago 5/8/25 to 5/8/26	1 Year Ago 8/6/24 to 8/6/25
Strong Buy	0 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	15 Buy rating(s)	15 Buy rating(s)	16 Buy rating(s)	15 Buy rating(s)
Hold	7 Hold rating(s)	6 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$339.45	$338.30	$338.35	$377.72
Forecasted Upside	23.32% Upside	18.02% Upside	17.48% Upside	39.87% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Cigna Group Stock vs. The Competition

Type	Cigna Group	Healthcare Companies	Broader Market
Consensus Rating Score	2.68	2.31	2.53
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	24.00% Upside	881.34% Upside	11.93% Upside
News Sentiment Rating	Positive News See Recent CI News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
8/4/2026	Jefferies Financial Group 2 of 5 stars	David Windley Not Rated	Downgrade	Buy ➝ Hold	$336.00 ➝ $307.00	+8.76%
8/3/2026	Raymond James Financial 3 of 5 stars	Sarah James Not Rated	Downgrade	Strong-Buy ➝ Outperform	$350.00 ➝ $320.00	+14.58%
7/31/2026	Robert W. Baird 3 of 5 stars		Set Target		$362.00	+26.90%
7/31/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Cassorla Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$338.00 ➝ $361.00	+25.54%
7/31/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Baxter Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$305.00 ➝ $307.00	+6.76%
7/31/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Andrew Mok Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Equal Weight	$304.00 ➝ $310.00	+7.80%
7/9/2026	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lance Wilkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$371.00 ➝ $381.00	+31.43%
6/16/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$315.00	+7.17%
6/8/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ann Hynes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$330.00 ➝ $340.00	+18.07%
6/3/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Lower Target	Overweight	$370.00 ➝ $346.00	+26.40%
Get the Latest News and Ratings for CI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cigna Group and its competitors with MarketBeat's FREE daily newsletter.
6/1/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)
5/22/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	A.J. Rice Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$375.00 ➝ $400.00	+41.92%
5/20/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Erin Wright Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$355.00 ➝ $361.00	+23.90%
5/20/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	George Hill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$303.00 ➝ $302.00	+3.65%
5/4/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Buy	$335.00 ➝ $340.00	+20.08%
5/1/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Sarah James Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$325.00 ➝ $340.00	+19.68%
5/1/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Hendrix Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$333.00 ➝ $337.00	+19.19%
2/17/2026	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David MacDonald Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$320.00 ➝ $350.00	+20.13%
2/9/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Charles Rhyee Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$333.00 ➝ $338.00	+14.97%
2/6/2026	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Boost Target	Market Perform	$270.00 ➝ $297.00	+2.82%
1/5/2026	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Strong Sell ➝ Hold
11/4/2025	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lisa Gill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$428.00 ➝ $375.00	+42.26%
1/31/2025	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Wiederhorn Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$400.00 ➝ $375.00	+26.31%
1/31/2025	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raj Kumar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$410.00 ➝ $380.00	+28.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:18 PM ET.

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, July 30, 2026. Please send any questions or comments about these Cigna Group pros and cons to contact@marketbeat.com.

Cigna Group
Bull Case

Here are some ways that investors could benefit from investing in The Cigna Group:

The current stock price is around $340, reflecting a positive outlook from analysts who have recently upgraded their ratings.
The Cigna Group has a solid dividend payout ratio of 26.45%, indicating a commitment to returning value to shareholders through dividends.
Recent analyst reports show a consensus rating of "Moderate Buy," with multiple firms raising their price targets, suggesting strong future performance.
The company offers a diverse range of healthcare products and services, catering to various customer segments, which can help mitigate risks associated with market fluctuations.
With a growing focus on health services and insurance solutions, The Cigna Group is well-positioned to benefit from increasing demand in the healthcare sector.

Cigna Group
Bear Case

Investors should be bearish about investing in The Cigna Group for these reasons:

Despite positive ratings, some analysts have lowered their price targets, indicating potential volatility in the stock's performance.
The healthcare industry faces regulatory challenges that could impact profitability and operational efficiency for companies like The Cigna Group.
Market competition is intense, with numerous players vying for market share, which could pressure margins and growth prospects.
Economic uncertainties may affect consumer spending on healthcare products, potentially impacting The Cigna Group's revenue streams.
Investors should be cautious of the company's reliance on government programs like Medicare and Medicaid, which can be subject to policy changes and funding issues.

CI Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Cigna Group is $339.45, with a high forecast of $400.00 and a low forecast of $297.00.

22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cigna Group in the last twelve months. There are currently 7 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CI shares.

According to analysts, Cigna Group's stock has a predicted upside of 23.32% based on their 12-month stock forecasts.

Over the previous 90 days, Cigna Group's stock had 5 downgrades by analysts.

Cigna Group has been rated by research analysts at Barclays, Deutsche Bank Aktiengesellschaft, Guggenheim, Jefferies Financial Group, Mizuho, Morgan Stanley, Piper Sandler, Raymond James Financial, Robert W. Baird, Sanford C. Bernstein, UBS Group, Weiss Ratings, Wells Fargo & Company, and Wolfe Research in the past 90 days.

Analysts like Cigna Group more than other "healthcare" companies. The consensus rating for Cigna Group is Moderate Buy while the average consensus rating for "healthcare" companies is Hold. Learn more on how CI compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cigna Group Recommendations

This page (NYSE:CI) was last updated on 8/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CI Analyst Ratings Over Time

CI Analyst Recommendations By Month

CI Price Targets by Month

Cigna Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

Cigna Group
Bull Case

Cigna Group
Bear Case

CI Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cigna Group Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

CI Analyst Ratings Over Time

CI Analyst Recommendations By Month

CI Price Targets by Month

Cigna Group Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

Should I Buy Cigna Group Stock? CI Pros and Cons Explained

Cigna Group Bull Case

Cigna Group Bear Case

CI Forecast - Frequently Asked Questions

What is Cigna Group's forecast for 2026?

Should I buy or sell Cigna Group stock right now?

Does Cigna Group's stock price have much upside?

Has Cigna Group been downgraded by Wall Street analysts recently?

What analysts cover Cigna Group?

Do Wall Street analysts like Cigna Group more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Cigna Group Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

Cigna Group
Bull Case

Cigna Group
Bear Case